Critical Assessment of a Structure-Based Pipeline for Targeting the Long Noncoding RNA MALAT1.

Area of Science:

• Biochemistry
• Computational Biology
• Drug Discovery

Background:

• Long noncoding RNAs (lncRNAs) are emerging as critical regulators in diseases.
• The MALAT1 triple helix is a druggable target implicated in oncogenesis.
• Structure-based drug discovery (SBDD) offers a promising avenue for targeting RNA molecules.

Purpose of the Study:

• To evaluate a comprehensive SBDD pipeline for predicting ligand binding to the MALAT1 lncRNA.
• To assess the performance of molecular dynamics, pocket analysis, ensemble docking, and scoring functions.
• To identify potential binding modes and explain experimentally observed affinity trends for diminazene-based ligands.

Main Methods:

• Generated conformational ensembles of MALAT1 using conventional and replica exchange molecular dynamics (MD).
• Performed ensemble docking using AutoDock GPU and rDock against representative RNA conformations.
• Rescored docked poses using force-field and machine-learning scoring functions; analyzed interaction fingerprints.

Main Results:

• Identified two potential binding sites on the MALAT1 RNA.
• A specific binding mode showed the best agreement across a series of 21 diminazene-based ligands.
• Computational analysis successfully explained experimentally observed ligand affinity trends.

Conclusions:

• The evaluated SBDD pipeline demonstrates potential for targeting flexible RNA structures like MALAT1.
• Findings highlight both the capabilities and limitations of current computational methods for RNA drug discovery.
• This study provides a benchmark for advancing RNA-focused SBDD strategies.